Mark L. Berenblut, FCBV, FCA, CPA, ASA, CFE

In international arbitration, Mr. Berenblut has provided expert evidence before arbitrators and panels in Europe, the US, Canada, and Israel, examining disputes in the areas of pharmaceutical patents, shareholder disputes, post-acquisition, and other contract disputes. He has also provided economic evidence before the European Court of Human Rights. Mr. Berenblut is recognized as a leading expert witness in arbitration by Who’s Who Legal: Arbitration, in which peers and clients describe him as a seasoned professional, very knowledgeable, thorough, and diligent in his written work and oral testimony.  

Mr. Berenblut specializes in providing business, securities, and intellectual property valuation and damages analysis in commercial and IP, tax valuation for estate freeze, and transfer pricing. His expertise includes the valuation of securities and business interests, brands, establishing royalty rates, patent portfolio valuation, valuation of intangibles, and other IP.  

Mr. Berenblut provides expertise in insolvency and restructuring matters, particularly where they intersect with forensic investigation, business valuation, and economic damages quantification. He has been retained for leading insolvency cases including matters related to the bankruptcies of Nortel, the Stanford Investment Bank, Enron, and Olympia and York Developments. 

Mr. Berenblut has also been retained on behalf of insurers, directors and officers, and boards in connection with numerous securities class action cases in Canada and the US, as well as in regulatory hearings. 

Mr. Berenblut’s professional certifications include Accredited Senior Appraiser; CPA; Fellow Chartered Business Valuator; Certified Mediator; Certified Fraud Examiner; FCA (UK); and AICPA-CFF. He is recognized by the Academy of Experts and is the co-author/author of two books: The Litigator’s Guide to Expert Witnesses and Proving Economic Loss. He is recognized as a Fellow by the CBV Institute. He was a member of the Editorial Board of The Journal of Business Valuation and of the subcommittee of the CBV Institute’s Professional Practice Committee that revised the Code of Ethics. Mr. Berenblut was a managing partner of a US venture capital investment fund and a bio science fund and a member of the investment committees of several major charitable foundations.